Patents by Inventor Lori Hazelhurst

Lori Hazelhurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING ERO1 ALPHA WITH AURONE DERIVATIVES
    Publication number: 20250064773
    Abstract: Compounds and pharmaceutical compositions comprising a derivative of sulfuretin are provided that are inhibitors of the endoplasmic reticulum oxidoreductin-1 alpha. A method of treating a patient having cancer comprising administering to the patient a therapeutically effective amount of a compound that is a derivative of sulfuretin that are inhibitors of the endoplasmic reticulum oxidoreductin-1 alpha to a patient is disclosed.
    Type: Application
    Filed: December 13, 2022
    Publication date: February 27, 2025
    Applicants: West Virginia University Board of Governors on behalf of West Virginia University, Modulation Therapeutics, Inc.
    Inventors: Lori Hazelhurst, Werner Geldenhuys, Sridhar Reddy Kaulagari